gH-gL-gp-42-gp-350-D-123

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NamegH-gL-gp-42-gp-350-D-123
Drug Alias NamegH/gL/gp42+gp350D123gH-gL-gp-42-gp-350-D-123
ClassificationVaccines
Mechanisms of ActionEpstein-barr virus nuclear antigens
TargetsEpstein-barr virus nuclear antigens
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofi
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A